Medirom Healthcare [MRM] vs Yy Group Holding [YYGH] Detailed Stock Comparison
Medirom Healthcare
NASDAQ
Loading...
Yy Group Holding
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Medirom Healthcare wins in 11 metrics, Yy Group Holding wins in 4 metrics, with 0 ties. Medirom Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Medirom Healthcare | Yy Group Holding | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.79 | 20.23 | Medirom Healthcare |
| Price-to-Book Ratio | 0.02 | 2.27 | Medirom Healthcare |
| Debt-to-Equity Ratio | 400.54 | 81.32 | Yy Group Holding |
| EV/EBITDA | 12.55 | -3.43 | Yy Group Holding |
| Profit Margin (TTM) | 1.79% | -11.77% | Medirom Healthcare |
| Operating Margin (TTM) | 13.30% | -26.81% | Medirom Healthcare |
| EBITDA Margin (TTM) | 13.30% | N/A | N/A |
| Return on Equity | 22.96% | -93.74% | Medirom Healthcare |
| Return on Assets (TTM) | 0.04% | -24.14% | Medirom Healthcare |
| Free Cash Flow (TTM) | $-12.88M | $-1.60M | Yy Group Holding |
| 1-Year Return | -24.63% | -68.33% | Medirom Healthcare |
| Price-to-Sales Ratio (TTM) | 0.00 | 0.57 | Medirom Healthcare |
| Enterprise Value | $25.12M | $16.80M | Medirom Healthcare |
| EV/Revenue Ratio | 0.45 | 0.41 | Yy Group Holding |
| Revenue per Share (TTM) | $1,625 | $1 | Medirom Healthcare |
| Earnings per Share (Diluted) | $0.19 | $-0.14 | Medirom Healthcare |
| Beta (Stock Volatility) | 0.95 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Medirom Healthcare vs Yy Group Holding Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Medirom Healthcare | 2.50% | -30.27% | 31.41% | 45.39% | 197.10% | 102.97% |
| Yy Group Holding | 2.43% | 2.70% | -77.11% | -86.94% | -72.46% | -78.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Medirom Healthcare | -24.63% | -65.83% | -85.76% | -85.76% | -85.76% | -85.76% |
| Yy Group Holding | -68.33% | -87.07% | -87.07% | -87.07% | -87.07% | -87.07% |
Performance & Financial Health Analysis: Medirom Healthcare vs Yy Group Holding
| Metric | MRM | YYGH |
|---|---|---|
| Market Information | ||
| Market Cap | $22.68M | $23.31M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 10,159,742 | 1,177,781 |
| 90 Day Avg. Volume | 4,441,097 | 7,205,187 |
| Last Close | $2.05 | $0.38 |
| 52 Week Range | $0.34 - $5.30 | $0.32 - $3.45 |
| % from 52W High | -61.32% | -89.01% |
| All-Time High | $19.80 (Dec 28, 2020) | $4.70 (Apr 22, 2024) |
| % from All-Time High | -89.65% | -91.91% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.21% |
| Quarterly Earnings Growth | 0.55% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.12% |
| Operating Margin (TTM) | 0.13% | -0.27% |
| Return on Equity (TTM) | 0.23% | -0.94% |
| Debt to Equity (MRQ) | 400.54 | 81.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $118.11 | $0.17 |
| Cash per Share (MRQ) | $41.69 | $0.08 |
| Operating Cash Flow (TTM) | $-9,043,183 | $-1,501,880 |
| Levered Free Cash Flow (TTM) | $-7,118,298 | $-2,963,123 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Medirom Healthcare vs Yy Group Holding
| Metric | MRM | YYGH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.79 | 20.23 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 0.00 | 0.57 |
| Price to Book (MRQ) | 0.02 | 2.27 |
| Market Capitalization | ||
| Market Capitalization | $22.68M | $23.31M |
| Enterprise Value | $25.12M | $16.80M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.45 | 0.41 |
| Enterprise to EBITDA | 12.55 | -3.43 |
| Risk & Other Metrics | ||
| Beta | 0.95 | N/A |
| Book Value per Share (MRQ) | $118.11 | $0.17 |
Financial Statements Comparison: Medirom Healthcare vs Yy Group Holding
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MRM | YYGH |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MRM | YYGH |
|---|---|---|
| Cash & Equivalents | $2.24M | $836,907 |
| Total Current Assets | $18.38M | $13.41M |
| Total Current Liabilities | $28.40M | $7.96M |
| Long-Term Debt | $13.93M | $1.13M |
| Total Shareholders Equity | $8.07M | $6.19M |
| Retained Earnings | $1.56M | $-4.29M |
| Property, Plant & Equipment | $14.08M | $129,687 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MRM | YYGH |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MRM | YYGH |
|---|---|---|
| Shares Short | 249,309 | 1.75M |
| Short Ratio | 0.17 | 0.18 |
| Short % of Float | 0.04% | 0.05% |
| Average Daily Volume (10 Day) | 10,159,742 | 1,177,781 |
| Average Daily Volume (90 Day) | 4,441,097 | 7,205,187 |
| Shares Outstanding | 53,660 | 36.10M |
| Float Shares | 5.82M | 17.61M |
| % Held by Insiders | 0.26% | 2.87% |
| % Held by Institutions | 0.01% | 0.01% |
Dividend Analysis & Yield Comparison: Medirom Healthcare vs Yy Group Holding
| Metric | MRM | YYGH |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |